Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma.

Weaver J, Goldblum JR, Turner S, Tubbs RR, Wang WL, Lazar AJ, Rubin BP.

Mod Pathol. 2009 Jan;22(1):66-70. doi: 10.1038/modpathol.2008.153.

2.

Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms.

Weaver J, Downs-Kelly E, Goldblum JR, Turner S, Kulkarni S, Tubbs RR, Rubin BP, Skacel M.

Mod Pathol. 2008 Aug;21(8):943-9. doi: 10.1038/modpathol.2008.84.

3.

Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma.

Erickson-Johnson MR, Seys AR, Roth CW, King AA, Hulshizer RL, Wang X, Asmann YW, Lloyd RV, Jacob EK, Oliveira AM.

Mod Pathol. 2009 Dec;22(12):1541-7. doi: 10.1038/modpathol.2009.149.

4.

Liposarcoma masquerading as an inflammatory pseudotumor: a case report.

Reagh JJ, Eckstein RP, Selinger CI, Evans J, O'Toole SA, Gill AJ.

J Med Case Rep. 2016 Mar 18;10:64. doi: 10.1186/s13256-016-0858-y.

5.

Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.

Kimura H, Dobashi Y, Nojima T, Nakamura H, Yamamoto N, Tsuchiya H, Ikeda H, Sawada-Kitamura S, Oyama T, Ooi A.

Int J Clin Exp Pathol. 2013 Jun 15;6(7):1306-16.

6.

Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.

Sirvent N, Coindre JM, Maire G, Hostein I, Keslair F, Guillou L, Ranchere-Vince D, Terrier P, Pedeutour F.

Am J Surg Pathol. 2007 Oct;31(10):1476-89.

PMID:
17895748
7.

Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.

Chung L, Lau SK, Jiang Z, Loera S, Bedel V, Ji J, Weiss LM, Chu PG.

Am J Surg Pathol. 2009 Nov;33(11):1594-600. doi: 10.1097/PAS.0b013e3181accb01.

PMID:
19574885
8.

Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.

Mariño-Enríquez A, Fletcher CD, Dal Cin P, Hornick JL.

Am J Surg Pathol. 2010 Aug;34(8):1122-31. doi: 10.1097/PAS.0b013e3181e5dc49.

PMID:
20588177
9.

Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor.

Kashima T, Halai D, Ye H, Hing SN, Delaney D, Pollock R, O'Donnell P, Tirabosco R, Flanagan AM.

Mod Pathol. 2012 Oct;25(10):1384-96. doi: 10.1038/modpathol.2012.90.

10.

Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).

Creytens D, van Gorp J, Ferdinande L, Speel EJ, Libbrecht L.

Appl Immunohistochem Mol Morphol. 2015 Feb;23(2):126-33. doi: 10.1097/PDM.0000000000000041.

PMID:
25679065
11.

Automated Bright-Field Dual-Color In Situ Hybridization for MDM2: Interobserver Reproducibility and Correlation With Fluorescence In Situ Hybridization in a Series of Soft Tissue Consults.

Zhang G, Lanigan CP, Goldblum JR, Tubbs RR, Downs-Kelly E.

Arch Pathol Lab Med. 2016 Oct;140(10):1111-5. doi: 10.5858/arpa.2015-0249-OA.

PMID:
27684983
12.

Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma?

Weaver J, Rao P, Goldblum JR, Joyce MJ, Turner SL, Lazar AJ, López-Terada D, Tubbs RR, Rubin BP.

Mod Pathol. 2010 Oct;23(10):1301-6. doi: 10.1038/modpathol.2010.106.

13.

Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?

Le Guellec S, Chibon F, Ouali M, Perot G, Decouvelaere AV, Robin YM, Larousserie F, Terrier P, Coindre JM, Neuville A.

Am J Surg Pathol. 2014 Mar;38(3):293-304. doi: 10.1097/PAS.0000000000000131.

PMID:
24525499
14.

Automated brightfield dual-color in situ hybridization for detection of mouse double minute 2 gene amplification in sarcomas.

Zhang W, McElhinny A, Nielsen A, Wang M, Miller M, Singh S, Rueger R, Rubin BP, Wang Z, Tubbs RR, Nagle RB, Roche P, Wu P, Pestic-Dragovich L.

Appl Immunohistochem Mol Morphol. 2011 Jan;19(1):54-61. doi: 10.1097/PAI.0b013e3181ee8e14.

PMID:
20881839
15.

Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22.

Pilotti S, Della Torre G, Lavarino C, Sozzi G, Minoletti F, Vergani B, Azzarelli A, Rilke F, Pierotti MA.

J Pathol. 1998 Jun;185(2):188-90.

PMID:
9713346
16.
17.

Analysis of MDM2 Amplification in 43 Endometrial Stromal Tumors: A Potential Diagnostic Pitfall.

Schoolmeester JK, Sciallis AP, Greipp PT, Hodge JC, Dal Cin P, Keeney GL, Nucci MR.

Int J Gynecol Pathol. 2015 Nov;34(6):576-83. doi: 10.1097/PGP.0000000000000187.

PMID:
26444253
18.

Comparison of Chromogenic In Situ Hybridization and Fluorescence In Situ Hybridization for the Evaluation of MDM2 Amplification in Adipocytic Tumors.

Mardekian SK, Solomides CC, Gong JZ, Peiper SC, Wang ZX, Bajaj R.

J Clin Lab Anal. 2015 Nov;29(6):462-8. doi: 10.1002/jcla.21794.

PMID:
25132285
19.

MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma: characterizing progression to high-grade tumors.

Ware PL, Snow AN, Gvalani M, Pettenati MJ, Qasem SA.

Am J Clin Pathol. 2014 Mar;141(3):334-41. doi: 10.1309/AJCPLYU89XHSNHQO.

PMID:
24515760
20.

p16 Expression in Fat Necrosis: A Potential Diagnostic Pitfall in the Evaluation of Differentiated Adipocytic Neoplasms.

Ng W, Messiou C, Smith M, Thway K.

Int J Surg Pathol. 2015 Oct;23(7):544-8. doi: 10.1177/1066896915595465.

PMID:
26173427

Supplemental Content

Support Center